Biorepository: Cancer

Virginia Mason Benaroya Research Institute Tumor Repository


The Virginia Mason and Benaroya Research Institute Tumor Repository (VM BRITE) is a bank of blood and tissue samples from donors who have cancer. Surgeons at Virginia Mason Franciscan Health (VMFH) partner with scientists at BRI to study cancerous tumors and gain new insights into how and why cancer starts and what treatments are most effective.

VM BRITE also collects health information — including family history, medical history and genetic information — from people who participate in this biorepository. This gives researchers more insight into how and why various cancers happen and accelerates the pace toward new discoveries and cures.

We are also looking for family members of all ages who do not have cancer or other immune-mediated or autoimmune diseases, to join our Healthy Control Biorepository.

Participating in research typically involves a 45- minute to -one- hour visit to BRI in downtown Seattle. Our team will collect a blood sample and ask questions about your personal and family medical history. All samples and information are kept confidential. Learn more: Biorepository FAQ

Learn more about cancer and our research. 


    Donate to the BRITE Cancer biorepository

    Consider donating to our biorepository to help advance cancer research.
    Meg Mandelson
    Pancreatic Cancer Research Director

    Meg Mandelson, PhD

    Director, Pancreatic Cancer Research
    View Full Bio

    BRI scientists are conducting a wide variety of cancer research projects including:

    • Understanding the role a protein called TSLP plays in breast, colon, and pancreatic cancer as well as melanoma
    • See all of our Cancer Clinical Trials. 

    Labs Studying Cancer

    Bolouri Lab Main

    Bolouri Lab

    The Bolouri lab is interested in developing and applying computational systems immunology methods to better understand dysregulated immune cell development and differentiation.
    View Lab
    Buckner Lab Main

    Buckner Lab

    The Buckner Lab is focused on identifying the underlying mechanisms by which regulation of the adaptive immune response fails or is overcome in the setting of human autoimmunity. 
    View Lab
    Linsley Lab Main

    Linsley Lab

    Our goal is to develop and use cutting edge systems biology approaches to elucidate molecular signatures of complex immune diseases, understand the mechanisms of disease, and identify the right therapy for the right patient.
    View Lab
    Speake Research Project Main - TrialNet Pathway to Prevention

    Speake Lab

    The Speake group is interested in advancing clinical research – especially in type 1 diabetes, but also in the context of other immune-mediated diseases.
    View Lab
    Stefani Lab Main

    Stefani Lab

    The goal of our research is to better understand mechanisms of sensing and repair during diseases like cancer, infections, and neurodegenerative disorders.
    View Lab
    Ziegler Lab Main

    Ziegler Lab

    The Ziegler laboratory is investigating the role of the epithelial cytokines TSLP and IL-33 in regulating protective responses at mucosal barrier surfaces such as the respiratory and gastrointestinal tracts.
    View Lab

    Blog Stories

    Feature - Clinical Research Subject Blue
    September 19, 2023

    An Insider's Look Into Clinical Trials at BRI

    Before medicines become widely available, they have to be rigorously tested — first in the lab, then in people through clinical trials.
    Read Article
    Blog Main 3D Biological Anatomy Pancreas
    June 30, 2023

    Using Epidemiology to Fight Pancreas Cancer

    It only took one statistic to get Meg Mandelson, PhD, interested in studying pancreas cancer. “Five-year survival rates have greatly improved for almost every cancer over the past two decades,” she says. “Pancreas cancer is one of the few that hasn’t.” 
    Read Article
    Blog Main Image - Paper DNA Profile People
    March 14, 2023

    Computer Science Reveals Possible Drug Target for Deadly Childhood Leukemia

    Dr. Bolouri is an expert in using computer science to advance biomedical research. Working with Soheil Meshinchi, MD, PhD, and his team at Fred Hutch Cancer Center, they made a recent discovery that may lead to new treatments for certain forms of pediatric acute myeloid leukemia (AML).
    Read Article

    Immuno-what? Hear the latest from BRI

    Keep up to date on our latest research, new clinical trials and exciting publications.